Sight Diagnostics
In Brief This Week: Cepheid, Biocartis, Sight Diagnostics, Fluidigm, Co-Diagnostics, and More
News items for in vitro diagnostics industry for the week of Jan. 10, 2022.
Sight Diagnostics, Phoenix Capital Ink Distribution Deal in Middle East for Point-of-Care Analyzers
Phoenix will distribute Sight OLO blood analyzers initially in the United Arab Emirates, followed by the rest of the Gulf Cooperation Council region.
Sight Diagnostics Raises $71M in Series D Financing Round
Koch Disruptive Technologies, Longliv Ventures, and OurCrowd participated in the round, bringing the firm's total funding to date to more than $124 million.
In the long term, the company is developing a plan to create more tests based on its technology, which digitizes blood samples and turns them into images.
Sight Diagnostics Closes $27.8M Series C Funding
The firm's CTO Sarah Levy said the Series C funding will enable it to expand R&D activities to develop applications beyond complete blood counts.
Aug 13, 2018